Susquehanna International Group’s Biolase, Inc. BIOL Stock Holding History

Susquehanna International Group’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1	Closed	-$34K	–	10202
2014 Q3	$34K	Sell	1 -2	-67%	-$56.6K	﹤0.01%	9282
2014 Q2	$75K	Buy	3 +1	+50%	+$25.5K	﹤0.01%	9516
2014 Q1	$75K	Buy	+2	New	+$69.8K	﹤0.01%	8639
2013 Q4	–	Sell	-1	Closed	-$26K	–	9439
2013 Q3	$26K	Buy	+1	New	+$32.2K	﹤0.01%	8302

Other funds holding BIOL

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's BIOL Position: Q2 2024 in Review

Susquehanna International Group sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 36,649 shares — an estimated $6.96K sold.

Susquehanna International Group first reported a position in BIOL in Q3 2013 and held it in 13 quarters. The position peaked at $76K in Q2 2014. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.

Susquehanna International Group reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 36,649 Biolase, Inc. shares in Q2 2024, an estimated $6.96K.
Susquehanna International Group first reported a position in Biolase, Inc. in Q3 2013 and held it in 13 quarters.
Susquehanna International Group's Biolase, Inc. position peaked at $76K in Q2 2014.
2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.